Sab Biotherapeutics, Inc. (SABSW) SEC Filings — 2025
13 SEC filings for Sab Biotherapeutics, Inc. (SABSW) in 2025.
Filings
- SAB Biotherapeutics Files 8-K on Warrants — 8-K · Dec 29, 2025
- SAB Biotherapeutics Swings to Profit on Warrant Revaluation, PIPE Infusion — 10-Q · Nov 14, 2025
- SAB Biotherapeutics Files 8-K on Officer/Director Changes — 8-K · Sep 30, 2025
- SAB Biotherapeutics Files 8-K on Director/Officer Changes & Shareholder Votes — 8-K · Sep 26, 2025
- SAB Biotherapeutics Seeks Shareholder Nod for Major Dilution, Equity Boost — DEF 14A · Aug 29, 2025
- SAB Biotherapeutics' Q2 Loss Widens on Grant Revenue Drop — 10-Q · Aug 7, 2025
- SAB Biotherapeutics Files 8-K: Agreements, Equity Sales, Bylaw Changes — 8-K · Jul 21, 2025
- SAB Biotherapeutics Files 8-K on Shareholder Vote Matters — 8-K · Jul 17, 2025
- SAB Biotherapeutics Sets Virtual Annual Meeting for July 17 — DEF 14A · Jun 2, 2025
- SAB Biotherapeutics Files Q1 2025 10-Q — 10-Q · May 9, 2025
- SAB Biotherapeutics Files 2024 10-K, Details Warrants — 10-K · Mar 31, 2025
- SAB Biotherapeutics Files 8-K on Definitive Agreement & Asset Deal — 8-K · Feb 5, 2025
- SAB Biotherapeutics Files 8-K with Warrant Details — 8-K · Jan 28, 2025